Overview

Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to demonstrate the bioequivalence of Azithromycin Monohydrate 600 mg Tablets.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Sandoz
Treatments:
Azithromycin
Criteria
Inclusion Criteria:

- No clinically significant abnormal findings on physical exam, medical history, or
clinical laboratory results on screening

Exclusion Criteria:

- Positive test results for HIV or hepatitis B or C

- Treatment for drug or alcohol dependence

- Female subjects who are pregnant or lactating